DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Surya Roshni Limited — Press Release

NSE 1 hr ago·11 Aug 2026, 9:15 am

Surya Roshni

Surya Roshni Limited has announced its financial results for the first quarter of fiscal year 2027. The company filed a press release with the stock exchanges to disclose its performance metrics for the period ending June 30, 2026. This update provides investors with the latest data on the company's operational and financial health.

For investors, this announcement is a key milestone as it offers the first glimpse into the company's performance for the new financial year. It helps gauge the company's current trajectory and operational efficiency. Investors should focus on the revenue growth, profit margins, and any commentary provided by management regarding future outlook.

Moving forward, market participants will closely watch the company's performance in subsequent quarters. Any significant deviation from market expectations or changes in management guidance could impact the stock's valuation. Investors should monitor the release for detailed financial figures and strategic commentary.